[1]陈静,格桑顿珠,索朗次仁,等.藏药复方八味獐芽菜的性味、配伍研究[J].西部中医药,2019,32(02):70-74.
　CHEN Jing,GESANG Dunzhu,SUOLANG Ciren,et al.Study on the Property and Flavor, Compatibility of Tibetan Medicine Compound BaWei ZhangYaCai[J].Western Journal of Traditional Chinese Medicine,2019,32(02):70-74.
点击复制

藏药复方八味獐芽菜的性味、配伍研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年02期
页码:
70-74
栏目:
出版日期:
2019-02-15

文章信息/Info

Title:
Study on the Property and Flavor, Compatibility of Tibetan Medicine Compound BaWei ZhangYaCai
文章编号:
1004-6852(2019)02-0070-05
作者:
陈静，格桑顿珠，索朗次仁，金英
西藏藏医药大学，西藏 拉萨 850000
Author(s):
CHEN Jing, GESANG Dunzhu, SUOLANG Ciren, JIN Ying
Tibetan Traditional Medical College Lase 850000，China
关键词:
藏药; 八味獐芽菜; 方剂; 配伍
Keywords:
Tibetan medicine;  BaWei ZhangYaCai;  prescription;  compatibility
分类号:
R932
摘要:
目的：对藏药复方八味獐芽菜组成药材的味、性、效、入方率及其药对的入方率进行分析。方法：采用文献法查阅资料，整理，归纳，统计，总结。结果：8种组成药材均味苦、性寒，入方率由高至低的顺序为木香、榜嘎、波棱瓜子、兔耳草、獐芽菜、小檗皮、角茴香、岩参。比较了672个藏药方剂，发现药对獐芽菜-波棱瓜子、獐芽菜-木香、獐芽菜-兔耳草、獐芽菜-榜嘎、波棱瓜子-榜嘎、波棱瓜子-榜嘎的入方率在2%以上。结论：入方率越高，说明该药材或药对的使用率越高，越常用。木香药对的入方率远低于木香单味药材的入方率，这可能是由于木香多作为仅起抑菌作用的辅药入药。
Abstract:
Objective：To summarize the property, flavour, effects, entering-prescription rate of Tibetan medicine compound BaWei ZhangYaCai and the entering-prescription rate of couplet medicines. Methods: Literature method was used to consult, collect, conclude and summarize the data. Results: Eight kinds of herbs were bitter and cold, the herbs ranked in the entering-prescription rate from high to low: MuXiang (Common Vladimiria Root), BangGa(wolf-bane), BoLengGuaZi (Semen Herpetospermi), TuErCao (Lagotis glauca), ZhangYaCai (Swertia mussoti), XiaoBoPi (Berberis kansuensis Schneid), JiaoHuiXiang (Hypecoum erectum) and YanShen [Cicerbita azurea (Ledeb.) Beavuerd]. After comparing 672 Tibetan medicine prescriptions, it was found that the entering-prescription rates of ZhangYaCai-BoLengGuaZi, ZhangYaCai-MuXiang, ZhangYaCai-TuErCao, ZhangYaCai-BangGa and BoLengGuaZi-BangGa，and the entering-prescription rate of Boleug Guazi-BangGa waswere higher than 2%. Conclusion: The higher the entering-prescription rate is, the higher the frequency of the herbs or couplet medicines is, and the more commonly the herbs are used. The enteringprescription rates of couplet medicines containing MuXiang are far lower than that of only MuXiang, and this might be related to that MuXiang owns antibacterial activity as an adjuvant drug.

相似文献/References:

[1]邱建智.藏药学基础理论与方剂配伍规律的探析[J].西部中医药,2013,26(01):64.
　QIU Jianzhi.Probing into Theoretical Foundation and Prescription Compatibility Rules of Tibetan Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(02):64.
[2]杨宏权,贡布东智△,刘玉玲,等.藏药制剂康速能补胶囊的药效学研究[J].西部中医药,2012,25(08):53.
　YANG Hong-quan,GONG BU Dong-zhi,LIU Yu-ling,et al.Pharmacodynamics of Tibetan Agent KangSu NengBu Capsule[J].Western Journal of Traditional Chinese Medicine,2012,25(02):53.
[3]温丽芳,吴文弼,赵守宁,等.藏药独一味滴丸治疗阻生齿拔除术后并发症疗效观察[J].西部中医药,2013,26(08):53.
　WEN Lifang,WU Wenbi,ZHAO Shouning,et al.Observation on Tibetan DuYiWei Dripping Pills for the Complications after the Extraction of Impacted Tooth[J].Western Journal of Traditional Chinese Medicine,2013,26(02):53.
[4]冯德海,更桑,安维梅.藏药治疗银屑病60例临床疗效观察[J].西部中医药,2012,25(05):46.
　FENG De-hai,GENG Sang,AN Wei-mei.Observation on Curative Effects of Tibetan Medicine in Treating 60 Cases of Psoriasis[J].Western Journal of Traditional Chinese Medicine,2012,25(02):46.
[5]孟宪华,陈德道,张樱山,等.藏药“桑蒂”抗肝损伤作用机制研究[J].西部中医药,2014,27(01):135.
　MENG Xianhua,CHEN Dedao,ZHANG Yingshan,et al.Study on the Mechanism of Tibetan Medicine "SangDi" Fighting against Liver Damage[J].Western Journal of Traditional Chinese Medicine,2014,27(02):135.
[6]柳永明,雷宁波,董林,等.藏药内服外敷治疗痛风性关节炎40例[J].西部中医药,2014,27(04):57.
　LIU Yongming,LEI Ningbo,DONG Lin,et al.Treatment for 40 Cases of Gouty Arthritis by Tibetan Medicine for Oral Administration and External Use[J].Western Journal of Traditional Chinese Medicine,2014,27(02):57.
[7]莫生祥,莫庆智.藏药配合中医火龙疗法治疗腰椎间盘突出症的临床疗效观察[J].西部中医药,2015,28(11):68.
[8]胡君茹,姜 华,李喜香.对藏药甘青青兰4种提取物抑菌作用的研究[J].西部中医药,2014,27(06):10.
　HU Junru,JIANG Hua,LI Xixiang.Study on Antibacterial Activity of Four Kinds of Extracts from Tibetan Medicine GanQing QingLan[J].Western Journal of Traditional Chinese Medicine,2014,27(02):10.
[9]刘青,杜守颖△,次仁,等.藏药螃蟹甲的研究概况*[J].西部中医药,2014,27(12):138.
[10]陈静,索朗次仁,石云,等.藏药土木香化学成分、药理活性及其藏药方的研究进展[J].西部中医药,2017,30(10):137.
　CHEN Jing,SuoLang CiRen,SHI Yun,et al.Research Progress of Chemical Composition, Pharmacological Activity of Tibetan Medicine TuMuXiang and Its Application in the Prescription[J].Western Journal of Traditional Chinese Medicine,2017,30(02):137.

备注/Memo

备注/Memo:
收稿日期：2018-07-07 *基金项目：西藏自治区自然基金项目(编号14-64)。 作者简介：陈静(1979—)，女，硕士学位，副教授。研究方向：药物化学。
更新日期/Last Update: 2019-02-15